Industry / Canada
Pharmacies Accused Of Price Gouging
October 2007 | Industry NewsA report by Canada's Competition Bureau claims that patients are paying too much for generic drugs, despite ample competition in the system, because rebates offered by drugmakers are not being passed onto
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
